2023
DOI: 10.1016/s0016-5085(23)02149-2
|View full text |Cite
|
Sign up to set email alerts
|

Sa2003 TACROLIMUS AS BRIDGE THERAPY FOR VEDOLIZUMAB AND USTEKINUMAB IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: EXPERIENCE AND OUTCOMES IN A TERTIARY CENTER IN SOUTH FLORIDA

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles